Related Experiment Video
Updated: Mar 19, 2026

07:22
Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
9.8K
Atopic predisposition in cholinergic urticaria patients and its implications
S Altrichter1, K Koch1, M K Church1
1Department of Dermatology and Allergology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Summary
Atopic predisposition is common in cholinergic urticaria (CholU), affecting over half of patients, particularly females. This link suggests shared causes and highlights the need to screen all CholU patients for atopy.
Area of Science:
- Dermatology
- Immunology
- Allergy
Background:
- Cholinergic urticaria (CholU) is a common chronic hives condition triggered by heat or exercise.
- Previous reports suggest a higher prevalence of atopy in CholU patients, but its clinical significance remains unclear.
Purpose of the Study:
- To determine the prevalence and relevance of atopy in patients with cholinergic urticaria.
- To investigate the association between atopic predisposition and disease characteristics in CholU.
Main Methods:
- Thirty CholU patients were evaluated for atopic predisposition using the Erlangen Atopy Score.
- Patients were categorized into atopic and non-atopic groups and assessed for disease severity (CholUSI), activity (CholUAS7), quality of life (DLQI, CU-Q2OL), seasonal patterns, IgE levels, and comorbidities.
Main Results:
- Over half (57%) of CholU patients exhibited atopic predisposition, with higher rates in females.
- Higher atopy scores correlated with increased CholU severity, activity, and quality of life impairment.
- Atopic CholU patients displayed distinct seasonal exacerbation patterns, IgE specificity, and comorbidity profiles compared to non-atopic individuals.
Conclusions:
- Atopic predisposition is significantly linked to cholinergic urticaria, suggesting shared underlying pathogenetic mechanisms.
- Atopic CholU patients experience more severe disease and a reduced quality of life.
- Routine assessment for atopic predisposition is recommended for all patients diagnosed with cholinergic urticaria.
Related Concept Videos
Allergic Reactions: Anaphylaxis
119
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
119
Asthma: Pathogenesis and Management
1.6K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.6K
Allergic Reactions
33.3K
Overview
33.3K
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
1.8K
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
1.8K
Drug Toxicity: Allergic Reactions
106
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
106
Cholinergic Antagonists: Pharmacokinetics
1.1K
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
1.1K

